Search Count: 21
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.56 Å Release Date: 2025-01-22 Classification: HYDROLASE Ligands: A1IA0, NA |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2025-01-22 Classification: HYDROLASE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.52 Å Release Date: 2025-01-22 Classification: HYDROLASE Ligands: A1IA2, NA, EDO |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.14 Å Release Date: 2025-01-22 Classification: HYDROLASE Ligands: A1IA1, EDO |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.61 Å Release Date: 2022-07-27 Classification: TRANSFERASE Ligands: 3UI, NO3 |
 |
Crystal Structure Of Human Ddr2 Kinase In Complex With 2-[4,5-Difluoro-2-Oxo-1'-(1H-Pyrazolo[3,4-B]Pyridine-5-Carbonyl)Spiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl)Acetamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.87 Å Release Date: 2018-11-28 Classification: TRANSFERASE Ligands: D6Q |
 |
Ddr1, 2-[8-(1H-Indazole-5-Carbonyl)-4-Oxo-1-Phenyl-1,3,8-Triazaspiro[4.5]Decan-3-Yl]-N-Methylacetamide, 1.440A, P1211, Rfree=24.1%
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.44 Å Release Date: 2018-11-28 Classification: TRANSFERASE Ligands: D6W |
 |
Ddr1, 2-[4-Bromo-2-Oxo-1'-(1H-Pyrazolo[4,3-B]Pyridine-5-Carbonyl)Spiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl)Acetamide, 1.291A, P212121, Rfree=17.4%
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.29 Å Release Date: 2018-11-28 Classification: TRANSFERASE Ligands: D6Z, IOD, MES, CL |
 |
Ddr1, 2-[8-(1H-Indazole-5-Carbonyl)-4-Oxo-1-Phenyl-1,3,8-Triazaspiro[4.5]Decan-3-Yl]-N-Methylacetamide, 1.730A, P212121, Rfree=24.5%
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2018-11-28 Classification: TRANSFERASE Ligands: D6W, IOD |
 |
Ddr1, 3-[(3-Cyclopropyl-1,2,4-Oxadiazol-5-Yl)Methyl]-8-(1H-Indazole-5-Carbonyl)-1-Phenyl-1,3,8-Triazaspiro[4.5]Decan-4-One, 1.670A, P1211, Rfree=22.8%
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2018-11-28 Classification: TRANSFERASE Ligands: IOD, DJQ |
 |
Ddr1, 2-[1'-(1H-Indazole-5-Carbonyl)-4-Methyl-2-Oxospiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl)Acetamide, 1.990A, P6522, Rfree=27.7%
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2018-11-28 Classification: TRANSFERASE Ligands: DJH |
 |
Ddr1, 1-(1H-Indazole-5-Carbonyl)-5'-Methoxy-1'-[2-Oxo-2-[(2S)-2-(Trifluoromethyl)Pyrrolidin-1-Yl]Ethyl]Spiro[Piperidine-4,3'-Pyrrolo[3,2-B]Pyridine]-2'-One, 1.790A, P212121, Rfree=23.8%
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2018-11-28 Classification: TRANSFERASE Ligands: DJW, CL |
 |
Crystal Structure Of Btk Kinase Domain Complexed With 6-(Dimethylamino)-2-[2-(Hydroxymethyl)-3-[1-Methyl-5-[[5-(Morpholine-4-Carbonyl)-2-Pyridyl]Amino]-6-Oxo-3-Pyridyl]Phenyl]-3,4-Dihydroisoquinolin-1-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2014-12-24 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 3OU, DMS |
 |
Crystal Structure Of Btk Kinase Domain Complexed With 6-(Dimethylamino)-8-Fluoro-2-[2-(Hydroxymethyl)-3-[1-Methyl-5-[[5-(Morpholine-4-Carbonyl)-2-Pyridyl]Amino]-6-Oxo-3-Pyridyl]Phenyl]Isoquinolin-1-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.17 Å Release Date: 2014-12-24 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 3OV, DMS |
 |
Crystal Structure Of Btk Kinase Domain Complexed With 2-[8-Fluoro-2-[2-(Hydroxymethyl)-3-[1-Methyl-5-[[5-(4-Methylpiperazin-1-Yl)-2-Pyridyl]Amino]-6-Oxo-3-Pyridyl]Phenyl]-1-Oxo-3,4-Dihydroisoquinolin-6-Yl]-2-Methyl-Propanenitrile
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2014-12-24 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 3P0 |
 |
Crystal Structure Of Btk Kinase Domain Complexed With 4-Tert-Butyl-N-(3-{8-[4-(4-Methyl-Piperazine-1-Carbonyl)-Phenylamino]-Imidazo[1,2-A]Pyrazin-6-Yl}-Phenyl)-Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2014-05-14 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 481, DMS |
 |
Crystal Structure Of Btk Kinase Domain Complexed With 4-Methanesulfonyl-N-(3-{8-[4-(Morpholine-4-Carbonyl)-Phenylamino]-Imidazo[1,2-A]Pyrazin-6-Yl}-Phenyl)-Benzamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2014-05-14 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 2V1 |
 |
Crystal Structure Of Btk Kinase Domain Complexed With 1-[5-[3-(7-Tert-Butyl-4-Oxo-Quinazolin-3-Yl)-2-Methyl-Phenyl]-1-Methyl-2-Oxo-3-Pyridyl]-3-Methyl-Urea
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2014-05-14 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 2V2, DMS |
 |
Crystal Structure Of Btk Kinase Domain Complexed With 6-Cyclopropyl-2-[3-[5-[[5-(4-Ethylpiperazin-1-Yl)-2-Pyridyl]Amino]-1-Methyl-6-Oxo-3-Pyridyl]-2-(Hydroxymethyl)Phenyl]-8-Fluoro-Isoquinolin-1-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2014-05-14 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 2V3, DMS |
 |
Structure Of Human Dpp-Iv With Hts Hit (2S,3S,11Bs)-3-Butyl-9,10-Dimethoxy-1,3,4,6,7,11B-Hexahydro-2H-Pyrido[2,1-A]Isoquinolin-2-Ylamine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2010-08-25 Classification: HYDROLASE Ligands: NAG, B2Q |